LensGen, Inc.
Ophthalmic medical device company that has developed a biomimetic, Curvature Changing Fluid-Optic Intraocular Lens designed for the treatment of cataracts and presbyopia.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
$10.0m Valuation: $55.0m | Late VC | ||
| Total Funding | 000k | ||
Related Content
LensGen is an ophthalmic medical device company specializing in the development of innovative intraocular lenses (IOLs) designed to mimic the natural human lens. The company's core product is a curvature-changing, fluid optic intraocular lens that aims to rejuvenate youthful vision for individuals affected by cataracts and presbyopia. This advanced lens works with the eye's natural accommodation mechanism to provide a continuous range of vision from distance to near, eliminating the need for reading glasses.
LensGen operates in the global ophthalmic market, targeting patients undergoing cataract surgery, which is performed in over 28 million procedures annually worldwide. The company's business model revolves around the development, clinical testing, and eventual commercialization of its proprietary lens technology. Revenue generation is expected through the sale of these advanced intraocular lenses to eye care professionals and surgical centers once regulatory approvals are obtained.
Keywords: intraocular lens, cataract surgery, presbyopia, vision correction, fluid optic, curvature-changing, ophthalmic device, natural accommodation, youthful vision, eye care.